- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Article 3(i)
Column 1 | Column 2 | Column 3 | Column 4 | Column 5 |
---|---|---|---|---|
Substance | Maximum strength | Route of administration, use or pharmaceutical form | Treatment limitations | Maximum quantity |
Aloxiprin | (1) 620 mg | (1) Non-effervescent tablets and capsules | (1) The quantity sold or supplied in one container or package shall not exceed 32
| |
(2) All preparations other than non-effervescent tablets or capsules | ||||
Diphenhydramine Hydrochloride | All preparations except liquid-filled capsules | |||
Hydrocyanic Acid | ||||
Ibuprofen Lysine | Rheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza | |||
Internal | (a)In the case of a prolonged release preparation 600 mg (MD) 1,200 mg (MDD) (b)in any other case 400 mg (MD) 1,200 mg (MDD) | |||
Levocabastine Hydrochloride | Equivalent of 0.05 per cent Levocabastine | (1) Nasal sprays For the symptomatic treatment of seasonal allergic rhinitis | (1) Container or package containing not more than 10 ml of medicinal product | |
(2) Aqueous eye drops For the symptomatic treatment of seasonal allergic conjunctivitis | (2) Container or package containing not more than 4 ml of medicinal product | |||
Nilutamide | ||||
Phytomenadione | Any use except the prevention or treatment of haemorrhagic disorders | |||
Strychnine Nitrate | ||||
Sulfabenzamide |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: